Jessica Velardi, PA
Medical · Orange, CTNPI 1215325147
Payments from drug & device makers
Across 675 payments — averaging $21.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$2K
- Incyte Corporation$2K
- Pfizer$1K
- Regeneron Healthcare Solutions, Inc.$1K
- LEO Pharma Inc.$867
- plus $6K from 25 others
What the payments were for
- Food & beverage$13,95695%
- Education$7025%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 123 | $1,858 |
| Johnson & Johnson | 47 | $1,577 |
| Incyte Corporation | 64 | $1,516 |
| Pfizer | 63 | $1,376 |
| Regeneron Healthcare Solutions, Inc. | 46 | $1,112 |
| LEO Pharma Inc. | 62 | $867 |
| Amgen | 31 | $743 |
| Sun Pharmaceutical Industries Inc. | 33 | $711 |
| Lilly USA, LLC | 29 | $677 |
| UCB, Inc. | 24 | $600 |
| Sanofi | 17 | $468 |
| Arcutis Biotherapeutics, Inc. | 21 | $419 |
| Galderma Laboratories, L.p. | 16 | $411 |
| E.r. Squibb & Sons, L.L.C. | 23 | $408 |
| Novartis | 16 | $337 |
| Almirall LLC | 14 | $273 |
| Dermavant Sciences, Inc. | 9 | $261 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 11 | $225 |
| Revance Therapeutics, Inc. | 1 | $149 |
| Merz North America, Inc. | 1 | $134 |
| VYNE Pharmaceuticals Inc. | 4 | $113 |
| Organon | 4 | $99 |
| Mayne Pharma Commercial LLC | 4 | $97 |
| Boehringer Ingelheim | 2 | $48 |
| Verrica Pharmaceuticals Inc. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| Journey Medical Corporation | 2 | $28 |
| EPI Health, LLC | 1 | $22 |
| Botanix SB Inc | 1 | $21 |
| LNHC, Inc | 1 | $15 |
| Nabriva Therapeutics, PLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,658 in reported general payments places this provider in the 95th percentile of 592 medical providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 59 | $227,944 |
| Cosentyx Unoready PenSecukinumab | 11 | $135,612 |
| Taltz AutoinjectorIxekizumab | 11 | $74,034 |
| Tacrolimus | 22 | $3,181 |
| Metronidazole | 27 | $2,047 |
| Clobetasol Propionate | 54 | $1,915 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 25 | $1,837 |
| Ketoconazole | 132 | $1,441 |
| Tretinoin | 14 | $1,172 |
| Doxycycline Hyclate | 46 | $797 |
| Triamcinolone Acetonide | 64 | $757 |
| Clindamycin Phosphate | 31 | $680 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 32 | $589 |
| Fluticasone Propionate | 24 | $515 |
| Ciclopirox | 12 | $450 |
Paid to pharmacies, not to this prescriber.
Other medical in Orange
- Elizabeth ChoeOrange$13K
- Shilpa DesaiStamford$215K
- Gregory RauNew Haven$211K
- John JasinskiNorwalk$185K
- Brianna PaesanoStamford$153K
- Debra SullivanDerby$100K
- Ryan DonovanNew Haven$75K
- Jonica PagnuccoWaterbury$32K
- Alyssa GreenleafSouthington$26K
- Mark VolpeSuffield$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.